Home Compare BMRN vs MDB
Stock Comparison · Structural lead, mixed market

BioMarin Pharmaceutical vs MongoDB: Which Stock Looks Stronger in 2026?

The structural profiles are close, with BioMarin Pharmaceutical carrying a narrow edge on stability. MongoDB still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.

Updated 2026-08-16

The lead is spread across stability and profitability, rather than sitting in one isolated gap.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #10
within BioMarin Pharmaceutical Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The match is driven mainly by investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMRN
BioMarin Pharmaceutical Inc.
32
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
MDB
MongoDB, Inc.
31
Peer-Score
Signal qualitylow
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BMRN vs MDB Profitability 40 10 Stability 65 29 Valuation 12 41 Growth 16 49 BMRN MDB
Gap Ranking
#1 Stability +36
#2 Growth +33
#3 Profitability +30
#4 Valuation +29
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMRN and MDB Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMRNMDB Relative valuation Structural strength

BioMarin Pharmaceutical Inc. looks stronger, but the price setup still looks more supportive for MongoDB, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Entry today — historical context

Where BMRN and MDB each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BMRN Neutral · near norm 0th 50th 100th 60 pct gap MDB Elevated · near norm 0th 50th 100th 33rd 93rd
Today BMRN sits in the lower-middle of its own 5-year history (33rd percentile), while MDB sits higher in its own history (93rd). Within each stock's own 5-year context, BMRN is at a historically more favourable entry position than MDB. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
On stability, BioMarin Pharmaceutical Inc. ranks near the top of the group; MongoDB, Inc. sits in the weaker half.
Growth
MongoDB, Inc. sits higher in the group on growth, adding to the overall structural advantage.
Stability — Dominant Gap
BMRN
65
MDB
29
Gap+36in favour of BMRN

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Growth still tilts materially toward MongoDB, Inc., which stops the result from looking dominant across the whole profile.

What this means for the comparison

The lead is built on both stability and growth — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BMRN vs MDB comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BMRN and MDB each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.